Dyslipidaemia
Showing 1 - 25 of 629
Healthy Volunteers, Dyslipidaemia Trial in Cypress (NNC0491-6075, Placebo)
Recruiting
- Healthy Volunteers
- Dyslipidaemia
- NNC0491-6075
- Placebo
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Aug 8, 2023
Fixed-dose Combination Rosuvastatin/Ezetimibe for Dyslipidaemia
Completed
- Dyslipidemias
- Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Sleep Apnea, Dyslipidaemia Trial in Alcalá de Henares (device, behavioral, other)
Suspended
- Sleep Apnea
- Dyslipidaemia
- Continuous positive airway pressure
- +2 more
-
Alcalá de Henares, Madrid, SpainHospital Universitario Príncipe de Asturias
Feb 11, 2021
Dyslipidemia Associated With Type II Diabetes Trial in Mexico City (Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose,
Recruiting
- Dyslipidemia Associated With Type II Diabetes Mellitus
- Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose
- Atorvastatin (Lipitor ®)
-
Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Lipid Profile and Diabetes Mellitus in People With HIV
Recruiting
- HIV Infections
- +3 more
-
Vienna, AustriaSchalk:Pichler Gruppenpraxis
Apr 4, 2022
Relation Between NAFLD and BM DENSITY
Not yet recruiting
- NAFLD
- Osteoporosis
- Fibroscan
- (no location specified)
Sep 14, 2023
Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)
Not yet recruiting
- Lupus Nephritis
- Chronic Kidney Diseases
- Dapagliflozin 10mg Tab
- Standard maintenance therapy
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 24, 2023
Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe
Not yet recruiting
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed dose combination with ezetimibe
- (no location specified)
Mar 23, 2023
Hypertension, Dyslipidemia Trial in Canada, United Kingdom (Amlodipine/Atorvastatin)
Completed
- Hypertension
- Dyslipidemia
-
Calgary, Alberta, Canada
- +125 more
Jan 26, 2021
Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With
Active, not recruiting
- COVID-19 Pneumonia
- +4 more
-
Faro, Portugal
- +1 more
Apr 26, 2023
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated
Recruiting
- Type 2 Diabetes Mellitus in Obese
- Dyslipidemia Associated With Type II Diabetes Mellitus
- Chinese herb medicine
-
Beijing, Beijing, ChinaGuang'anmen Hospital, China Academy of Chinese Medical Sciences
Apr 6, 2022
Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis
Recruiting
- Type2diabetes
- Clinical Examination
-
Delhi, IndiaFortis CDOC Hospital
Jul 11, 2023
Pollutants in Atherosclerotic Plaque and Cardiovascular Events
Recruiting
- Atherosclerosis
- analysis of carotid atherosclerotic plaque
-
Naples, ItalyCelestino Sardu
Jun 12, 2023
Acute Coronary Syndrome, Myocardial Infarction, Ischemic Stroke Trial in Dudley (Decision Support System (DSS))
Recruiting
- Acute Coronary Syndrome
- +2 more
- Decision Support System (DSS)
-
Dudley, West Midlands, United KingdomRussell's Hall Hospital
Apr 25, 2023
Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)
Not yet recruiting
- Hypercholesterolemia
- +3 more
- Inclisiran
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Jan 13, 2023
Patterns With Use of Saxenda® in Real-life Settings in
Enrolling by invitation
- Obesity or Overweight
-
Soeborg, DenmarkNovo Nordisk Investigational Site
Dec 15, 2021
Diabetes Trial in Beijing (Berberine Chloride, Placebo)
Completed
- Diabetes Mellitus
- Berberine Chloride
- Placebo
-
Beijing, Beijing, China
- +1 more
Jul 14, 2023
Hyperlipidemia Trial in Leuven (Cholesfytol NG®) supplement)
Completed
- Hyperlipidemia
- Cholesfytol NG®) supplement
-
Leuven, BelgiumCliniques universitaires St-Luc and Institut de Recherche Expéri
Aug 18, 2023
Cardiovascular Disease, Stroke, Primary Prevention Trial in Yibin (The strategic use of messages in risk communication)
Completed
- Cardiovascular Disease
- +2 more
- The strategic use of messages in risk communication
-
Yibin, Sichuan, ChinaHealth center of Sipo town
Mar 9, 2022
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
-
Amman, Jordan
- +1 more
Nov 23, 2022
Coronary Heart Disease, Diabetes, Type 2, Periodontitis Trial in Denizli (clinical periodontal measurements, CAVI measurements)
Completed
- Coronary Heart Disease
- +3 more
- clinical periodontal measurements
- CAVI measurements
-
Denizli, TurkeyPamukkale University Faculty of Dentistry
May 10, 2023
Diabetes Mellitus and HIV Study in Mwanza
Active, not recruiting
- Diabetes Mellitus
- HIV/AIDS
-
Mwanza, Mwanza Region, TanzaniaNIMR Research Clinic
Jun 28, 2021
Rectal Cancer, Rectum Tumor Trial (Transanal local excision)
Not yet recruiting
- Rectal Cancer
- Rectum Neoplasm
- Transanal local excision
- (no location specified)
Jun 22, 2023
NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients
Not yet recruiting
- Nonalcoholic Fatty Liver Disease
- +3 more
- (no location specified)
Apr 18, 2022